• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results

    12/12/23 11:58:48 AM ET
    $ACHV
    $ADTX
    $CCCC
    $GGE
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHV alert in real time by email

    U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday.

    The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&P 500 also rose, gaining, 0.10% to 4,627.04

    Check This Out: Microsoft, U.S. Bancorp And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Industrials shares rose by 0.3% on Tuesday.

    In trading on Tuesday, energy shares fell by 1%.

     

    Top Headline

     

    Oracle Corporation (NYSE:ORCL) reported upbeat earnings for its second quarter, while sales missed estimates.

    Oracle reported quarterly adjusted earnings of $1.34 per share, topping the Street's estimate of $1.32. Revenue of $12.94 billion fell short of the analyst consensus estimate of $13.05 billion.

     

    Equities Trading UP

     

    Aditxt, Inc. (NASDAQ:ADTX) shares shot up 78% to $6.76. Aditxt agreed to acquire Evofem Biosciences in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.

    Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC) got a boost, surging 93% to $2.28. C4 Therapeutics entered into an exclusive license and collaboration agreement with Merck & Co to develop degrader-antibody conjugates (DACs), an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells.

    Icosavax, Inc. (NASDAQ:ICVX) shares were also up, gaining 48% to $15.51. AstraZeneca agreed to acquire Icosavax at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

     

    Equities Trading DOWN

     

    Achieve Life Sciences, Inc. (NASDAQ:ACHV) shares dropped 40% to $3.2697. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.

    Shares of Harbor Custom Development, Inc. (NASDAQ:HCDI) were down 26% to $0.5015. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.

    Green Giant Inc. (NASDAQ:GGE) was down, falling 40% to $0.0913 as the company announced pricing of public offering.

    Also Check This Out: Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

     

    Commodities

     

    In commodity news, oil traded down 2.5% to $69.52 while gold traded up 0.2% at $1,998.50.

    Silver traded up 0.3% to $23.13 on Tuesday while copper rose 0.1% to $3.7850.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 fell 0.21%, London’s FTSE 100 rose 0.02% while Spain’s IBEX 35 Index fell 0.63% The German DAX rose 0.01% French CAC 40 rose 0.06%, while Italy’s FTSE MIB Index fell 0.07%.

    The ZEW Indicator of Economic Sentiment for the Eurozone surged by 9.2 points to 23 in December, recording the strongest reading in ten months, while German ZEW Indicator of Economic Sentiment rose to 12.8 in December from 9.8 in November.

    The number of job vacancies in the UK fell to 949,000 from September to November, while regular pay, excluding bonus payment in the UK, rose 7.3% year-over-year to GBP 620/week in the three months to October.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 0.16%, Hong Kong’s Hang Seng Index gaining 1.07% and China’s Shanghai Composite Index gaining 0.40%. India’s S&P BSE Sensex, meanwhile, fell 0.54%.

    Producer prices in Japan increased 0.3% year-over-year in November following a revised 0.9% rise in October.

     

    Economics

     

    The NFIB Small Business Optimism Index declined for a fourth straight month to a reading of 90.6 in November.

    The annual inflation rate in the U.S. eased to 3.1% in November, recording the lowest reading in five months, compared to 3.2% in October.

    Now Read This: Top 5 Utilities Stocks That Should Keep You Up At Night

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ADTX
    $CCCC
    $GGE

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    1/12/2026$240.00Buy
    Goldman
    Oracle Corporation
    $ORCL
    12/11/2025$355.00 → $270.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    12/3/2025$280.00Overweight
    Wells Fargo
    C4 Therapeutics Inc.
    $CCCC
    12/2/2025Buy
    TD Cowen
    Achieve Life Sciences Inc.
    $ACHV
    11/25/2025$19.00Mkt Outperform
    Citizens JMP
    More analyst ratings

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously

    2/4/26 7:57:19 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Medical Officer Rubinstein Mark Lawrence

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:10:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Chief Financial Officer Oki Mark K

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:09:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Xinos Jaime

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:08:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    WATERTOWN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase 162,880 shares of the Company's common stock to one new employee (the "Inducement Grant"), with the grant made on February 9, 2026 (the "Grant Date"). The Inducement Grant was granted as a material inducement to this individual entering into employment with C4T in accordance with Nasdaq

    2/9/26 4:01:00 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Transform Shared Service Organization Improves EHR Performance and Drives AI Adoption with Oracle Cloud Infrastructure

    OCI helps five hospitals in Erie St. Clair region of Southwest Ontario enhance patient and provider experiences, improve data security, and increase resilience; also now piloting Oracle Health Clinical AI Agent  AUSTIN, Texas, Feb. 9, 2026 /PRNewswire/ -- The five hospitals supported by Transform Shared Service Organization (TSSO) in Ontario, Canada, have improved the performance, usability, and availability of their Oracle Health Foundation electronic health record (EHR) by migrating it to Oracle Cloud Infrastructure (OCI). With OCI, the hospitals can enhance the experience for patients and clinicians, scale efficiently, and easily adopt new AI-powered technologies, such as a recently launc

    2/9/26 9:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care

    Lumeo Regional Health Information System will leverage Oracle Health's voice-enabled, note generation technology to streamline clinical documentation and enhance care delivery AUSTIN, Texas, Feb. 4, 2026 /PRNewswire/ -- Lumeo Regional Health Information System (Lumeo RHIS) in Southeastern Ontario has selected Oracle Health Clinical AI Agent for a pilot project to streamline clinical documentation and reduce physicians' administrative workload so they can focus more time on caring for the people they serve. Representing six healthcare organizations across the region, the system's selection of Oracle Health Clinical AI Agent, an AI-powered, voice-enabled solution, builds on its mission of lev

    2/4/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Oki Mark K bought $28,887 worth of shares (10,000 units at $2.89) (SEC Form 4)

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    3/19/25 4:38:43 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    SEC Filings

    View All

    SEC Form CERT filed by Oracle Corporation

    CERT - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:24:57 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-A12B filed by Oracle Corporation

    8-A12B - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:18:28 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:01:31 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Leadership Updates

    Live Leadership Updates

    View All

    Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

    SEATTLE and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) --  Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation, today announced the appointment of Erik Atkisson as Chief Legal Officer. In his new role, Mr. Atkisson will oversee Achieve's legal strategy, corporate governance, compliance, and risk management. "Erik's extensive legal, regulatory and M&A background in the biopharmaceutical sector provides valuable experience as we advance cytisinicline through regulatory review and prepare for a potential laun

    10/20/25 8:30:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

    Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the 75 µg Dose Level in a Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma Patient Population Responses Across Dose Levels With Median Duration of Response of 9.3 Months as of the Data Cut-off Date; Median Duration of Response Not Yet Reached at Two Highest Doses No Discontinuations Related to Cemsidomide and Few Dose Reductions Support a Safety Profile That May Be Ideal for Combination Regimens C4T to Pursue Differentiated Development Strategy With Two Distinct Opportunities for Accelerated Approval in Second Line and Later C4T to Host Webc

    9/20/25 11:00:20 AM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Second Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on December 10, 2025, After the Close of the Market AUSTIN, Texas, Dec. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its second quarter fiscal year 2026 results will be released on Wednesday, December 10th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor.  About Oracle Oracle offers integrated suites of applications plus secure, a

    12/2/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

    SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its third quarter 2025 financial results and provide a corporate update on the cytisinicline development program on Thursday, November 6, 2025, at 8:30 AM EST. To access the webcast, please use the following link: 3Q25 Earnings Webcast. Alternatively, you may access the live conference call by dialing 888-396-8049 (U.S. & Canada) or 416-764-8646 (International) and

    10/29/25 8:30:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 7:53:04 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by C4 Therapeutics Inc.

    SC 13G - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 6:43:36 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 4:05:17 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care